A. Marc Gillinov, MD, Jon Sirak, MD, Eugene H

Slides:

Advertisements

Similar presentations

Tomislav Mihaljevic, MD, Edward R

Advertisements

A.Marc Gillinov, MD, Gosta Pettersson, MD, Thomas W. Rice, MD

Stapled excision of the left atrial appendage

Residual patient, anatomic, and surgical obstacles in treating active left-sided infective endocarditis Syed T. Hussain, MD, Nabin K. Shrestha, MD, Steven.

Surgical management of secondary tricuspid valve regurgitation: Annulus, commissure, or leaflet procedure? Jose L. Navia, MD, Edward R. Nowicki, MD,

Rounding numbers The Journal of Thoracic and Cardiovascular Surgery

Advising complex patients who require complex heart operations

Should lung transplantation be performed for patients on mechanical respiratory support? The US experience David P. Mason, MD, Lucy Thuita, MS, Edward.

A comprehensive review of the PARTNER trial

Do higher-risk patients benefit from off-pump coronary artery bypass grafting? Evidence from an ecologic analysis of randomized trials Oliver Kuss, PhD,

Lars G. Svensson, MD, PhD, Lillian H. Batizy, MS, Eugene H

Effect of changes in postoperative spirometry on survival after lung transplantation David P. Mason, MD, Jeevanantham Rajeswaran, MSc, Liang Li, PhD,

The least of 3 evils: Exposure to red blood cell transfusion, anemia, or both? Gabriel Loor, MD, Jeevanantham Rajeswaran, PhD, Liang Li, PhD, Joseph F.

Mitral Valve Surgery in the Adult Marfan Syndrome Patient

Surgical treatment of pseudoaneurysm of the thoracic aorta

Surgical Treatment of Postinfarction Left Ventricular Pseudoaneurysm

Edwin C. McGee, MD, A. Marc Gillinov, MD, Eugene H

Does preoperative carotid stenosis screening reduce perioperative stroke in patients undergoing coronary artery bypass grafting? Khalil Masabni, MD,

Duration of inotropic support after left ventricular assist device implantation: Risk factors and impact on outcome Soren Schenk, MD, Patrick M. McCarthy,

Surgical revascularization techniques that minimize surgical risk and maximize late survival after coronary artery bypass grafting in patients with diabetes.

Clostridium difficile infection after cardiac surgery: Prevalence, morbidity, mortality, and resource utilization Suresh Keshavamurthy, MBBS, MS, Colleen.

Surgical Repair of Posterior Mitral Valve Prolapse: Implications for Guidelines and Percutaneous Repair Douglas R. Johnston, MD, A. Marc Gillinov, MD,

Tricuspid valve repair: durability and risk factors for failure

Effects of right ventricular morphology and function on outcomes of patients with degenerative mitral valve disease Ying Ye, BS, Ravi Desai, MD, Lina.

A. Marc Gillinov, MD, Sekar Bhavani, MD, Eugene H

Multilevel data analysis: What? Why? How?

Does a similar procedure result in similar survival for women and men undergoing isolated coronary artery bypass grafting? Tamer Attia, MD, MSc, Colleen.

Simple versus complex degenerative mitral valve disease

A. Marc Gillinov, MD, Eugene H. Blackstone, MD, Edward R

Capturing echocardiographic allograft valve function over time after allograft aortic valve or root replacement M. Mostafa Mokhles, PhD, MSc, Jeevanantham.

Ahmad Zeeshan, MD, Jay J. Idrees, MD, Douglas R

Sunil K. Bhudia, MD, Delos M. Cosgrove, MD, Richard I

Understanding right ventricular dysfunction and functional tricuspid regurgitation accompanying mitral valve disease Lina Maria Vargas Abello, MD, Allan.

Challenging allograft use for aortic valve infective endocarditis: Is it the allograft or the surgeon? Syed T. Hussain, MD, Eugene H. Blackstone, MD,

Gabriel Loor, MD, Liang Li, PhD, Joseph F

Atrial fibrillation complicating lung cancer resection

Long-Term Durability of Bicuspid Aortic Valve Repair

A. Marc Gillinov, MD, Patrick M. McCarthy, MD, Eugene H

Farhang Yazdchi, MD, MS, Colleen G

del Nido versus Buckberg cardioplegia in adult isolated valve surgery

Outcomes of less invasive J-incision approach to aortic valve surgery

A time-related parametric risk factor analysis for postoperative atrial fibrillation after heart surgery Spencer J. Melby, MD, James F. George, PhD,

The variability of the mitral valve anatomy and terminology

A.Marc Gillinov, MD, Gosta Pettersson, MD, Thomas W. Rice, MD

Does the degree of preoperative mitral regurgitation predict survival or the need for mitral valve repair or replacement in patients with anomalous origin.

Distal aortic interventions after repair of ascending dissection: The argument for a more aggressive approach Eric E. Roselli, MD, Gabriel Loor, MD,

The influence of postoperative mitral valve function on the late recurrence of atrial fibrillation after the maze procedure combined with mitral valvuloplasty

Are allografts the biologic valve of choice for aortic valve replacement in nonelderly patients? Comparison of explantation for structural valve deterioration.

The Cox maze IV procedure: Predictors of late recurrence

Decision support in surgical management of ischemic cardiomyopathy

Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005 Scott D. Barnett, PhD,

J. Jay Idrees, MD, Eric E. Roselli, MD, Amr Arafat, MD, Douglas R

Lars G. Svensson, MD, PhD, Fernando A. Atik, MD, Delos M

Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD

The diabetes epidemic and its effect on cardiac surgery practice

Mohammed A Quader, MD, Patrick M McCarthy, MD, A

Colleen G. Koch, MD, MS, MBA, Edward R

Ventilatory dependency after cardiovascular surgery

Joseph F. Sabik, MD, Gabriel Olivares, MD, Sajjad Raza, MD, Bruce W

Douglas R. Johnston, MD, Edward G

Endocarditis after mitral valve repair

Turki B. Albacker, MD, MSc, Eugene H. Blackstone, MD, Sarah J

Mitral valve repair with aortic valve replacement is superior to double valve replacement A.Marc Gillinov, MD, Eugene H Blackstone, MD, Delos M Cosgrove,

Regional wall motion abnormalities and scarring in severe functional ischemic mitral regurgitation: A pilot cardiovascular magnetic resonance imaging.

Pulmonary hypertension is associated with worse early and late outcomes after aortic valve replacement: Implications for transcatheter aortic valve replacement

Commentary: Judgment day: Should you add atrial fibrillation ablation?

Identifying risk factors: Challenges of separating signal from noise

Fernando A. Atik, MD, Lars G. Svensson, MD, PhD, FACC, Eugene H

Left atrial to left ventricle bypass for mitral valve stenosis

Marc Gillinov, MD, Per Wierup, MD, PhD, Stephanie Mick, MD

Presentation transcript:

The Cox maze procedure in mitral valve disease: Predictors of recurrent atrial fibrillation A. Marc Gillinov, MD, Jon Sirak, MD, Eugene H. Blackstone, MD, Patrick M. McCarthy, MD, Jeevanantham Rajeswaran, MSc, Gosta Pettersson, MD, PhD, F. Joseph Sabik, MD, Lars G. Svensson, MD, PhD, Jose L. Navia, MD, Delos M. Cosgrove, MD, Nassir Marrouche, MD, Andrea Natale, MD The Journal of Thoracic and Cardiovascular Surgery Volume 130, Issue 6, Pages 1653-1660.e2 (December 2005) DOI: 10.1016/j.jtcvs.2005.07.028 Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Number of patients with electrocardiographic (ECG) follow-up available at and beyond various time points and number of ECGs available for analysis at and beyond these same time points. The Journal of Thoracic and Cardiovascular Surgery 2005 130, 1653-1660.e2DOI: (10.1016/j.jtcvs.2005.07.028) Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Temporal pattern of atrial fibrillation (AF) after ablation on the basis of postoperative electrocardiograms. A, Estimated prevalence of AF. The solid line represents mean prevalence, and dashed lines represent 68% confidence limits. B, Temporal decomposition of prevalence demonstrating 3 additive phases: an early peaking phase, a late phase, and a constant phase. The Journal of Thoracic and Cardiovascular Surgery 2005 130, 1653-1660.e2DOI: (10.1016/j.jtcvs.2005.07.028) Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Prevalence at 5 years of postoperative atrial fibrillation (AF) demonstrating effects of factors identified by multivariable analysis (Table 2). Except for the variables depicted, values for other risk factors were set as follows: duration of preoperative AF, 48 months; age, 62 years; creatinine, 1.0 mg·dL−1; hematocrit, 40%; left ventricular mass index, 125 g·m−2; left atrial (LA) diameter, 5.6 cm; right coronary artery stenosis, 0%. A, LA diameter. B, Duration of preoperative AF. C, Patient age. The Journal of Thoracic and Cardiovascular Surgery 2005 130, 1653-1660.e2DOI: (10.1016/j.jtcvs.2005.07.028) Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions

Electronic Figure Prevalence of class I/III antiarrhythmic agent and warfarin use after ablation. Horizontal axis begins at 3 months, marking the first systematic follow-up of patients. Filled circles are observed prevalences but only approximate the data because of multiple follow-up inquiries per patient. The solid line represents the prevalence estimate from logistic mixed model enclosed within dashed 68% confidence limits. A, Prevalence of class I/III antiarrhythmic agent use. B, Prevalence of warfarin use. The Journal of Thoracic and Cardiovascular Surgery 2005 130, 1653-1660.e2DOI: (10.1016/j.jtcvs.2005.07.028) Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions